Nuntius Therapeutics
Cell-specific genetic medicines
London, United Kingdom
2 employees
Gene Therapy
Seed · $125K
Company details
Team Size2
LocationLondon, United Kingdom
IndustryGene Therapy
Funding
Total raised
$125K
Last stage
Seed
Investors
UUncommon Denominator
AAsymmetry Ventures
Founders
Albert Kwok
Co-Founder and Chief Scientific Officer (PhD) at Nuntius Therapeutics, leading scientific development of cell-specific delivery technologies.
LinkedInBN
Benita Nagel
Co-Founder and CEO of Nuntius Therapeutics, a Y Combinator Winter 2021 biotech developing cell-specific mRNA and gene editing therapies.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
01
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
02
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
03
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.